Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies

Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies

Abstract Background The efficacy of bevacizumab combined with erlotinib (B + E) for the treatment of advanced hepatocellular carcinoma, especially for sorafenib-refractory patients, has been observed and evaluated in several trials. We conducted this single arm meta-analysis to generally assess the...

Full description

Bibliographic Details
Main Authors: Liyun He, Huan Deng, Jun Lei, Fengming Yi, Jine Li, Xiu De Fan, Yiping Wei, Jianjun Xu, Wenxiong Zhang
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Cancer
Subjects:
Meta-analysis
Bevacizumab
Erlotinib
Hepatocellular carcinoma
Sorafenib
Online Access:http://link.springer.com/article/10.1186/s12885-019-5487-6

Similar Items

Similar Items